Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases. (Q33810576)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21288181%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

Europe PubMed Central

Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21288181%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

congenital disorder

0 references

Massimiliano Cantinotti

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21288181%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Massimiliano Cantinotti

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21288181%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

5

object named as

Aldo Clerico

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21288181%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Stefania Giovannini

3

object named as

Stefania Giovannini

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21288181%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

4

object named as

Bruno Murzi

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21288181%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

3 February 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21288181%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Clinical Chemistry and Laboratory Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21288181%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

49

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21288181%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

567-580

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21288181%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21288181%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Evaluation of right ventricular function by using tissue Doppler imaging in patients after repair of tetralogy of fallot.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Effects of volume and/or pressure overload secondary to congenital heart disease (tetralogy of fallot or pulmonary stenosis) on right ventricular function using cardiovascular magnetic resonance and B-type natriuretic peptide levels.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Plasma brain natriuretic peptide levels, right ventricular volume overload and exercise capacity in adolescents after surgical repair of tetralogy of Fallot.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Aminoterminal brain-type natriuretic peptide levels correlate with heart failure in patients with bidirectional Glenn anastomosis and with morbidity after the Fontan operation.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Increased natriuretic peptide type B level after the second palliative step in children with univentricular hearts with right ventricular morphology but not left ventricular morphology

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Reference values for plasma B-type natriuretic peptide in the first days of life.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immunoassay platform.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Decision levels for plasma B-type natriuretic peptide assay to diagnose significant cardiovascular disease in children.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Clinical relevance of measurement of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in pediatric cardiology

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Determinants of natriuretic peptide gene expression

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Biosynthesis of cardiac natriuretic peptides

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age and gender.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Gap analysis of pediatric reference intervals for risk biomarkers of cardiovascular disease and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Normal values of B type natriuretic peptide in infants, children, and adolescents

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Plasma Concentrations of Aminoterminal Pro Atrial Natriuretic Peptide and Aminoterminal Pro Brain Natriuretic Peptide in Healthy Neonates: Marked and Rapid Increase After Birth

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

N-terminal pro-B-type natriuretic peptide concentrations are markedly higher in the umbilical cord blood of newborns than in their mothers.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

N-terminal pro-B-type natriuretic peptide concentrations in mothers just before delivery, in cord blood, and in newborns.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Correlation between cord blood, perinatal BNP values and echocardiographic parameters in healthy Italian newborns.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Cord blood, perinatal BNP values in term and preterm newborns.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

BNP concentrations and cardiovascular adaptation in preterm and fullterm newborn infants.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Discordant expression of pro-B-type and pro-C-type natriuretic peptide in newborn infants of mothers with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Brain-type natriuretic peptide at birth reflects foetal maturation and antenatal stress.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

NT-proBNP concentrations indicate cardiac disease in pediatric patients.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Utility of N-terminal pro-B-type natriuretic peptide to differentiate cardiac diseases from noncardiac diseases in young pediatric patients.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Diagnostic performance of BNP and NT-ProBNP measurements in children with heart failure based on congenital heart defects and cardiomyopathies.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Diagnostic accuracy and clinical relevance of brain natriuretic peptide assay in pediatric patients with congenital heart diseases.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

B-type natriuretic peptide in paediatric patients with congenital heart disease.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Clinical implication of plasma natriuretic peptides in children with ventricular septal defect.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

How useful are B-type natriuretic peptide measurements for monitoring changes in patent ductus arteriosus shunt magnitude?

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

B-type natriuretic peptide to predict ductus intervention in infants <28 weeks.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

The influence of percutaneous closure of patent ductus arteriosus on left ventricular size and function: a prospective study using two- and three-dimensional echocardiography and measurements of serum natriuretic peptides.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

B-type natriuretic peptide and heart failure in patients with ventricular septal defect: a pilot study.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Peri-operative changes in echocardiographic measurements and plasma atrial and brain natriuretic peptide concentrations in 3 dogs with patent ductus arteriosus.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

B-type natriuretic peptide levels in congenital heart disease.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Time course and prognostic value of plasma B-type natriuretic peptide concentration in neonates undergoing the arterial switch operation.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

B-type natriuretic peptide levels predict outcome after neonatal cardiac surgery.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Perioperative B-type natriuretic peptide levels predict outcome after bidirectional cavopulmonary anastomosis and total cavopulmonary connection

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Utility of N-terminal brain natriuretic peptide plasma concentrations in comparison to lactate and troponin in children with congenital heart disease following open-heart surgery

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Prognostic value of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart defects and open-heart surgery.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

B-type natriuretic peptide: perioperative patterns in congenital heart disease

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Value of plasma B-type natriuretic peptide as a marker for rejection in pediatric heart transplant recipients.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

B-type natriuretic peptide in children after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Usefulness of B-type natriuretic peptide as a noninvasive screening tool for cardiac allograft pathology in pediatric heart transplant recipients.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Cardiac transplantation affects ventricular expression of brain natriuretic peptide.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Palliative procedures for congenital heart defects

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

ESC Guidelines for the management of grown-up congenital heart disease (new version 2010).

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

ECG determinants in adult patients with chronic right ventricular pressure overload caused by congenital heart disease: relation with plasma neurohormones and MRI parameters

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Application of classic heart failure definitions of asymptomatic and symptomatic ventricular dysfunction and heart failure symptoms with preserved ejection fraction to patients with systemic right ventricles.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Plasma levels of B-type natriuretic peptide in patients with tetralogy of Fallot after surgical repair

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Evaluation of right ventricular functions and B-type natriuretic peptide levels by cardiopulmonary exercise test in patients with pulmonary regurgitation after repair of tetralogy of Fallot.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Amino-terminal fragment of pro-brain natriuretic hormone identifies functional impairment and right ventricular overload in operated tetralogy of Fallot patients.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Plasma N-terminal pro-brain natriuretic peptide as a marker of right ventricular dysfunction in patients with tetralogy of Fallot after surgical repair

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Assessment of biventricular functional reserve and NT-proBNP levels in patients with RV volume overload after repair of tetralogy of Fallot at young age.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

N-terminal pro-brain natriuretic peptide as a marker in follow-up patients with tetralogy of Fallot after total correction.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Brain natriuretic peptide and magnetic resonance imaging in tetralogy with right ventricular dilatation.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Elevated brain natriuretic peptide and reduced exercise capacity in adult patients operated on for tetralogy of fallot is due to biventricular dysfunction as determined by the myocardial performance index.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Clinical outcome 5 to 18 years after the Fontan operation performed on children younger than 5 years.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.106

21 January 2018

Identifiers

10.1515/CCLM.2011.106

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21288181%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21288181%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33810576&oldid=1744552386"